Cargando…

Critical arm ischemia—a rare presentation of giant cell arteritis

Giant cell arteritis can rarely present as severe ischemia of the upper limbs. The initial management includes high-dose oral glucocorticoids. However, when patients do not respond to medical therapy, surgical revascularization might be required to reinstitute limb perfusion. We present the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hage, Ali, Iannicello, Carman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144107/
https://www.ncbi.nlm.nih.gov/pubmed/34041422
http://dx.doi.org/10.1016/j.jvscit.2021.03.001
_version_ 1783696891058323456
author Hage, Ali
Iannicello, Carman
author_facet Hage, Ali
Iannicello, Carman
author_sort Hage, Ali
collection PubMed
description Giant cell arteritis can rarely present as severe ischemia of the upper limbs. The initial management includes high-dose oral glucocorticoids. However, when patients do not respond to medical therapy, surgical revascularization might be required to reinstitute limb perfusion. We present the case of a 68-year-old woman who had presented with critical arm ischemia that necessitated carotid–brachial artery bypass after initial oral steroid therapy had failed. We have delineated our surgical approach and technical considerations to potentially help increase the long-term patency of the bypass.
format Online
Article
Text
id pubmed-8144107
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81441072021-05-25 Critical arm ischemia—a rare presentation of giant cell arteritis Hage, Ali Iannicello, Carman J Vasc Surg Cases Innov Tech Case report Giant cell arteritis can rarely present as severe ischemia of the upper limbs. The initial management includes high-dose oral glucocorticoids. However, when patients do not respond to medical therapy, surgical revascularization might be required to reinstitute limb perfusion. We present the case of a 68-year-old woman who had presented with critical arm ischemia that necessitated carotid–brachial artery bypass after initial oral steroid therapy had failed. We have delineated our surgical approach and technical considerations to potentially help increase the long-term patency of the bypass. Elsevier 2021-03-23 /pmc/articles/PMC8144107/ /pubmed/34041422 http://dx.doi.org/10.1016/j.jvscit.2021.03.001 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case report
Hage, Ali
Iannicello, Carman
Critical arm ischemia—a rare presentation of giant cell arteritis
title Critical arm ischemia—a rare presentation of giant cell arteritis
title_full Critical arm ischemia—a rare presentation of giant cell arteritis
title_fullStr Critical arm ischemia—a rare presentation of giant cell arteritis
title_full_unstemmed Critical arm ischemia—a rare presentation of giant cell arteritis
title_short Critical arm ischemia—a rare presentation of giant cell arteritis
title_sort critical arm ischemia—a rare presentation of giant cell arteritis
topic Case report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144107/
https://www.ncbi.nlm.nih.gov/pubmed/34041422
http://dx.doi.org/10.1016/j.jvscit.2021.03.001
work_keys_str_mv AT hageali criticalarmischemiaararepresentationofgiantcellarteritis
AT iannicellocarman criticalarmischemiaararepresentationofgiantcellarteritis